Biofilm in group A streptococcal necrotizing soft tissue infections

Nikolai Siemens1, Bhavya Chakrakodi1, Srikanth Mairpady Shambat1

  • 1Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

JCI Insight
|October 5, 2016
PubMed

Insights

Group A Streptococcus (GAS) necrotizing soft tissue infections (NSTI) can involve biofilm, a factor not previously recognized. This finding suggests biofilm may complicate GAS NSTI, necessitating a review of antibiotic treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Dermatology

Background:

  • Necrotizing fasciitis caused by group A Streptococcus (GAS) is a severe, rapidly progressing infection.
  • Biofilm is typically associated with chronic infections or medical devices, not acute GAS infections.

Observation:

  • A case of GAS NSTI presented with a persistent infection and documented "thick layer biofilm" in the fascia.
  • Multicenter study revealed biofilm in 32% of GAS NSTI patient biopsies.
  • Biofilm-associated biopsies showed high bacterial load, inflammation, and severe tissue involvement.

Findings:

  • In vitro models demonstrated GAS NSTI isolates form multilayered fibrous biofilms.
  • The Nra gene regulator was identified as controlling GAS biofilm formation.
  • Biofilm formation is a previously unrecognized feature in GAS NSTI.

Implications:

  • Biofilm should be considered a potential complicating factor in GAS NSTI.
  • Current antibiotic treatment protocols for GAS NSTI may need reconsideration.
  • Further research into biofilm-disrupting therapies for GAS NSTI is warranted.